Last updated: August 23, 2021
Sponsor: Cognito Therapeutics, Inc.
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Alzheimer's Disease
Memory Problems
Learning Disorders
Treatment
N/AClinical Study ID
NCT03556280
CA-0005
Ages > 55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- >= 55 Years old
- MMSE 14-26
- Prodromal Alzheimer's Disease (AD), AD or Mild Cognitive Impairment (MCI) due to AD
- Participation of a caregiver
Exclusion
Exclusion Criteria:
- Profound hearing or visual impairment
- Seizure Disorder
- Use of memantine (Namenda or Namzaric)
- Implantable devices (non-MR compatible)
Study Design
Total Participants: 60
Study Start date:
April 24, 2018
Estimated Completion Date:
September 30, 2021
Study Description
Connect with a study center
Brain Matters Research
Delray Beach, Florida 33445
United StatesSite Not Available
Brain Matters Research
Stuart, Florida 34994
United StatesSite Not Available
ActivMed Practices & Research, Inc
Methuen, Massachusetts 01844
United StatesSite Not Available
Boston Center for Memory
Newton, Massachusetts 02459
United StatesSite Not Available
ActivMed Practices & Research, Inc
Portsmouth, New Hampshire 02801
United StatesSite Not Available
The Cognitive and Research Center of New Jersey
Springfield, New Jersey 07081
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.